IPOs pick up pace; venture capital gaining momentum
This article was originally published in Scrip
Executive Summary
The pipeline of biotechnology initial public offerings in the US returned to its frenzied state during the first week of September after the pace of IPO filings, price setting and completed offerings slowed somewhat in August.